Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZenGUARD
- Development stage
- Unknown
- Lead developer
- Zentek
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
ZenGUARD is a proprietary antimicrobial nanotechnology coating developed by Zentek Ltd. It consists of a synergistic compound of graphene oxide and silver designed to deactivate a broad spectrum of pathogens, including bacteria, fungi, and viruses such as SARS-CoV-2 and MRSA. The mechanism of action involves graphene oxide attracting pathogen-laden aerosols while silver provides biochemical antimicrobial effects; additionally, the graphene structure physically disrupts viral and bacterial cell walls. While initially commercialized as a coating for surgical masks and Class 1 medical devices (approved by Health Canada), Zentek is currently conducting pre-clinical research to transition the technology into therapeutic dermatological applications for conditions like acne, psoriasis, and eczema.
- Brand names
- ZenGUARD
- Other names
- graphene oxide-silver compound
02
Targets
Viral lipid envelope
Beyond the preview
Go deeper on ZenGUARD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZenGUARD.